Testing a Shortened Version of the AlAn's Game

March 17, 2020 updated by: University of Colorado, Denver

Testing a Shortened Version of the AlAn's Game, Which Can be Delivered Through REDCap, in a Sample of Emerging Adults

It has been demonstrated that behavior on the AlAn's (altruism-antisocial) game is related to Moral Elevation response. Moral Elevation is a positive response to another's act of generosity "of charity, gratitude, fidelity, generosity or any other strong display of virtue". The constellation of emotional, physical and psychological aspects of a Moral Elevation response have been well described. Moral Elevation can be elicited with stimulus stories or videos and measured with self-report questionnaires. The experience of Moral Elevation is associated with subsequent prosocial and affiliative behaviors. Additionally, the research has linked Moral Elevation response with behavior on the AlAn's game. This study will test whether behavior on the AlAn's Short Game v.2 is related to Moral Elevation response and extend prior work by testing whether viewing the Moral Elevation stimulus prior to playing the AlAn's Short Game v.2 is associated with differences in game behavior. The study will also test whether psychopathic traits will correlate with game behavior.

Study Overview

Detailed Description

Hypotheses and Specific Aims:

Aim 1: Examine the similarities and differences in behaviors on the AlAn's Short Game v.2 seen with the two Active Trial (AT) types (where Red Cross donation will be reduced and subject will gain money (AT1) vs. where the Red Cross donation will increase and study participants will lose money (AT2).

Hypothesis 1: Number of accepted trials of AT1 and AT2 from session 1 will significantly correlate.

Aim 2: Test the effects of Elevation vs. Nature video on change in AlAn's Short Game v.2 behavior between sessions 1 and 2.

Hypothesis 2: Subjects who view the Elevation stimulus video (study Arm 1) will show increases in prosocial behavior while those watching the Nature video will not.

Aim 3: Test the association between psychopathic traits and Costly Helping and determine whether the influence of Elevation on Costly Helping dissipates with increasing levels of psychopathic traits.

Hypothesis 3: Psychopathic traits, as measured by the Levenson Self Report Psychopathy Scale, will significantly and negatively correlate with the amount of prosocial behavior in session 1.

Hypothesis 4: Using subjects from study Arm 1, change in AlAn's Short game v.2 behavior (session 2 minus session 1) will be negatively correlated with psychopathic trait scores.

Study Type

Interventional

Enrollment (Actual)

537

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • University of Colorado Anschutz Medical Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

• age 18-25 years

Exclusion Criteria:

• refusal to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm 1 - Elevation Stimulus Video
All subjects complete the Levenson Psychopathy Scale first. Arm 1 then presents the Moral Elevation stimulus video after playing the first AlAn's Short Game v.2 (session 1). Participants will then play the AlAn's Short Game v.2 (session 2) for a second time and then fill out an Adverse Childhood Experiences Questionnaire (ACES), Social Connectedness survey, and Demographics form.
Subjects will watch a video that has been shown in previous studies to elicit an elevation response. This video shows a news story about a man saving the life of another man who falls onto the subway tracks.
Sham Comparator: Arm 2 - Control Stimulus Video
All subjects complete the Levenson Psychopathy Scale first. Arm 2 then presents the control stimulus (nature video) after playing the first AlAn's Short Game v.2 (session 1). Participants will then play the AlAn's Short Game v.2 (session 2) for a second time and then fill out an Adverse Childhood Experiences Questionnaire (ACES), Social Connectedness survey, and Demographics form.
Subjects will watch a nature video.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the Amount of Prosocial Behavior on the AlAn's Short Game v.2
Time Frame: within 45 minutes, during one single study visit

The primary outcome of interest is the change in the amount of prosocial behavior on the AlAn's Short game between sessions 1 and 2 (Costly Helping session 2 minus Costly Helping session 1).

Our two main analyses of interest using this outcome measure are: (1) to test whether viewing the Moral Elevation stimulus video vs. the Control video experience a greater change in Costly Helping (e.g., that Moral Elevation response promotes prosocial behavior); and (2) to test whether psychopathic traits attenuate the relationship between Moral Elevation and prosocial behavior (i.e., among those viewing the Moral Elevation stimulus video, that our primary outcome - change in prosocial behavior - will be negatively related to level of psychopathic traits).

within 45 minutes, during one single study visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joseph T Sakai, MD, University of Colorado, Denver

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 8, 2019

Primary Completion (Actual)

October 26, 2019

Study Completion (Actual)

October 26, 2019

Study Registration Dates

First Submitted

February 4, 2019

First Submitted That Met QC Criteria

February 5, 2019

First Posted (Actual)

February 8, 2019

Study Record Updates

Last Update Posted (Actual)

March 19, 2020

Last Update Submitted That Met QC Criteria

March 17, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

We will not share individual participant data. We might print the results of this research study in relevant journals or share aggregate data on that does not identify subjects with qualified investigators or as a supplement as required by some journals. However, the names and any other identifying information of research subjects will always be kept confidential and will not be shared. The data that may be shared in this manner include gender, age, and race/ethnicity, as well as responses from the AlAn's Game v.2, Levenson Psychopathy Scale, adverse childhood experiences questionnaire and social connectedness survey.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychopathic Personality Trait

Clinical Trials on Arm 1 - Elevation Stimulus Video

Subscribe